New: Introducing “Why Is It Moving?” - lightning-fast, AI-driven explanations of stock moves

Learn More
Last Close
Oct 21  •  04:00PM ET
31.14
Dollar change
-0.29
Percentage change
-0.91
%
CategoryUS Equities - Factor & Thematic Asset TypeEquities (Stocks) TagsDeveloped Return% 1Y- Total Holdings36 Perf Week3.89%
SponsorF/m Investments ETF Type Tagsequity Return% 3Y- AUM73.69M Perf Month5.56%
Fund Family Bond Type Tagsinnovation Return% 5Y- NAV/sh Perf Quarter21.47%
Index- Average Maturity Tagshealthcare Return% 10Y 52W High31.43 -0.91% Perf Half Y37.61%
Index Weighting Commodity Type Tagsbiotechnology Return% SI 52W Low18.78 65.81% Perf YTD33.13%
Active/Passive Quant Type Tagsmedical Flows% 1M1.36% Volatility1.03% 0.73% Perf Year-
Dividend TTM- ESG Type Tagspharmaceutical Flows% 3M3.56% ATR (14)0.45 Perf 3Y-
Dividend Ex-Date- Dividend Type Sector/Theme Flows% YTD10.99% RSI (14)65.36 Perf 5Y-
Dividend Gr. 3/5Y- - Structure Type Region Flows% 1Y Beta1.42 Perf 10Y-
Expense0.54% Growth/Value SMA203.75% Flows% 3Y Rel Volume0.39 Prev Close31.43
Inverse/Leveraged Market Cap SMA508.29% Flows% 5Y Avg Volume2.87K Price31.14
IPOOct 31, 2024 Option/ShortNo / Yes SMA20024.38% Trades Volume1,119 Change-0.91%
F/m Emerald Life Sciences Innovation ETF seeks long-term capital appreciation. The fund is an actively managed exchange-traded fund ("ETF") and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund's investment sub-adviser, under the supervision of the adviser. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation.